RGLS
D.E. Shaw & Co’s Regulus Therapeutics RGLS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q1 | – | Sell |
-27,319
| Closed | -$28K | – | 2634 |
|
2017
Q4 | $28K | Sell |
27,319
-2,409
| -8% | -$2.47K | ﹤0.01% | 2489 |
|
2017
Q3 | $37K | Buy |
+29,728
| New | +$37K | ﹤0.01% | 2445 |
|
2017
Q1 | – | Sell |
-61,881
| Closed | -$139K | – | 2575 |
|
2016
Q4 | $139K | Buy |
61,881
+5,007
| +9% | +$11.2K | ﹤0.01% | 2385 |
|
2016
Q3 | $187K | Buy |
+56,874
| New | +$187K | ﹤0.01% | 2343 |
|
2016
Q2 | – | Sell |
-68,682
| Closed | -$476K | – | 2649 |
|
2016
Q1 | $476K | Sell |
68,682
-38,585
| -36% | -$267K | ﹤0.01% | 2082 |
|
2015
Q4 | $935K | Buy |
107,267
+55,433
| +107% | +$483K | ﹤0.01% | 1792 |
|
2015
Q3 | $339K | Buy |
+51,834
| New | +$339K | ﹤0.01% | 2192 |
|
2015
Q2 | – | Sell |
-12,508
| Closed | -$212K | – | 2710 |
|
2015
Q1 | $212K | Buy |
+12,508
| New | +$212K | ﹤0.01% | 2359 |
|
2013
Q4 | – | Sell |
-25,411
| Closed | -$240K | – | 2600 |
|
2013
Q3 | $240K | Buy |
+25,411
| New | +$240K | ﹤0.01% | 2160 |
|